Latest News
Ampio Pharmaceuticals, Inc. Announces Statistically Significant Improvement in Pain Relief for its Lead Product, Ampion™ in the Osteoarthritis of the Knee Trial
01/31/2012 | Press Release
Register Now For AMPIO’s January 26, 2012 Outlook Call
01/26/2012 | News
Ampio Pharmaceuticals' Zertane™ Patent Estate Bolstered by Two New European Patents
01/17/2012 | Press Release
Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
01/17/2012 | Press Release
Executive Changes at Ampio
01/09/2012 | Press Release
Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
01/05/2012 | Press Release
Ampio Pharmaceuticals Completes Expanded Patient Enrollment for Ampion™ In Osteoarthritis of the Knee Clinical Trial in Australia
01/03/2012 | Press Release
Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
12/23/2011 | Press Release
Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
12/21/2011 | Press Release
Ampio Responds to Recent Publications by Anonymous Short Sellers
12/16/2011 | Press Release
Years: 2012 | 2011 | 2010
Learn More About:
Premature Ejaculation (PE)
Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.
Diabetic Retinopathy
A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness
Diabetic Nephropathy
A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis
| AMPE Stock Quote - delayed | ||
| Last | Change | |
| AMPE | ||
Ampio News
01/31/2012 | Press Release
01/26/2012 | News
Register Now For AMPIO’s January 26, 2012 Outlook Call
01/17/2012 | Press Release
Ampio Pharmaceuticals' Zertane™ Patent Estate Bolstered by Two New European Patents